CTKB Stock Analysis: Buy, Sell, or Hold?
CTKB - Cytek Biosciences, Inc. Common Stock
$3.36
-0.33 (-8.83%)
▼
5d:
-31.81%
30d:
-28.46%
90d:
-19.54%
WAIT
LOW Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When CTKB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CTKB is down 31.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CTKB is down 31.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CTKB is currently trading at $3.35, which is considered oversold relative to its 30-day fair value range of $4.18 to $4.81. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.4) compared to its historical average (90.3). Remarkably, the market is currently pricing in an annual earnings decline of 40.1% over the next few years. This pessimistic expectation contrasts with the company's recent 73.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CTKB is in a downtrend. The price is currently testing key support at $3.31. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 8.8% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.00 (+63.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CTKB is in a downtrend. The price is currently testing key support at $3.31. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 8.8% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.00 (+63.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.18 -
$4.81
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.8%)
- BULLISH: Trading 63.0% below Wall St target ($6.00)
- WARNING: Recommendation downgraded due to -31.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$4.18 -
$4.81
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.31
Resistance Level
$4.99
Current Trend
Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.37
Wall Street Target
$6.00
(+63.0%)
Revenue Growth (YoY)
6.5%
Earnings Growth (YoY)
73.5%
Profit Margin
-36.2%
Valuation Discount vs History
-40.1% cheaper
PE vs Historical
19.4 vs 90.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-40.1%
(market-implied from PE analysis)
1-Year Target
$3.31
(-10%)
2-Year Target
$2.98
(-19%)
3-Year Target
$2.68
(-27%)
3-Yr Target (if PE normalizes)
(PE: 19→90)
$12.51
(+240%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.4 to 90.3
Stabilization Target:
$17.16
(+366.2%)
PE Expansion Potential:
+366.2%
Share & Embed Analysis
Last updated: May 14, 2026 4:32 PM ET
Data refreshes hourly during market hours. Next update: 5:32 PM
Data refreshes hourly during market hours. Next update: 5:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTKB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 55 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$392 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 62 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 58 HOLD |
